BTMD
NASDAQ
Pharmaceuticals
$2.43
USD
+$0.05 (+2.10%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$89.44M
Volume:
298.4K
Previous Close
$2.38
Day Range
$2.29 - $2.53
52 Week Range
$1.27 - $4.75
Average Volume (10 Days)
210.0K
P/E Ratio (TTM)
5.73
Dividend Yield
—
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
CEO
Mr. Bret Christensen
Headquaters
Irving, TEXAS, US
Founded
2021
Employees
223
NTHI
NeOnc Technologies Holdings Inc
$3.46
+6.5%
RANI
Rani Therapeutics Holdings Inc
$0.7000
+4.1%
TELO
Telomir Pharmaceuticals Inc
$1.11
-6.7%